Andrew R Allen Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew R Allen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew R Allen. Andrew R Allen is a Chief Medical Officer, EVP in PHARMION CORP ($PHRM) and a Director in Sierra Oncology, Inc. ($SRRA) and a See Remarks in Clovis Oncology, Inc. ($CLVS) and a Director in Epizyme, Inc. ($EPZM) and a President and CEO in Gritstone Oncology, Inc. ($GRTS) and a Director in TCR2 THERAPEUTICS INC. ($TCRR).
Address: 2525 28TH STREET SUITE 200 BOULDER 80301 CO
Companies in which Andrew R Allen is an Insider
Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: See Remarks
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 04 2015
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Director
Holdings: 12,500 shares
Current Value: $150,625
Latest Transaction: Jun 02 2020
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gritstone bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew R Allen: President and CEO
Holdings: 0 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PHARMION CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Chief Medical Officer, EVP
Holdings: 0 shares
Latest Transaction: Mar 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew R Allen: Director
Holdings: 66,000 shares
Latest Transaction: Jun 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew R Allen: Director
Holdings: 0 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew R Allen
Sentiment: All, CLVS, EPZM, GRTS, PHRM, SRRA, TCRR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | GRTS | Gritstone Oncology ... | Allen Andrew R | President and CEO | Option Exercise | A | 13.87 | 290,000 | 4,022,300 | 290,000 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Jun 10 2020 | SRRA | Sierra Oncology, I ... | Allen Andrew R | Director | Option Exercise | A | 13.98 | 12,030 | 168,179 | 12,030 | |
| Jun 02 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Mar 18 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | M | 9.33 | 12,500 | 116,625 | 0 | |
| Mar 18 2020 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Buy | M | 9.33 | 12,500 | 116,625 | 12,500 | 0 to 12.5 K |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 |